IQV250516P135000
- 1.76
- +0.16+10.00%
IQVIA Holdings Newsroom
New Analyst Forecast: $IQV Given $160.0 Price Target
IQVIA Holdings Inc. (IQV): Among Billionaire Israel Englander's Stock Picks With Huge Upside Potential
Goldman Sachs: The Q1 performance of U.S. pharmaceutical stocks is reassuring, and the Industry sentiment is slightly becoming more positive.
Goldman Sachs stated that amid cautious sentiment from investors towards the USA pharmaceutical sector before the Earnings Reports season, the performance of USA pharmaceutical companies that have reported results so far for the first quarter has not been worse than expected, and in some cases, it has even exceeded expectations.
The Trump administration plans to impose tariffs on imported Pharmaceuticals, and the U.S. Pharmaceutical Industry warns that it may increase drug costs.
A report commissioned by a trade organization in the USA Pharmaceutical Industry indicates that if the USA imposes a 25% tariff on imported Pharmaceuticals, it could increase the annual Pharmaceutical costs in the USA by nearly 51 billion dollars and raise drug prices by up to 12.9%.
Beyond The Numbers: 12 Analysts Discuss IQVIA Hldgs Stock
IQVIA Hldgs Analyst Ratings
HSBC Downgrades IQVIA Holdings(IQV.US) to Hold Rating, Cuts Target Price to $160
HSBC Downgrades IQVIA to Hold From Buy, Adjusts Price Target to $160 From $260
Press Release: IQVIA to Announce First-Quarter 2025 Results on May 6, 2025
Jefferies Maintains IQVIA Holdings(IQV.US) With Hold Rating, Cuts Target Price to $165
Express News | IQVIA Holdings Inc : Jefferies Cuts Target Price to $165 From $205
Shareholders Will Probably Hold Off On Increasing IQVIA Holdings Inc.'s (NYSE:IQV) CEO Compensation For The Time Being
Trump Signs Executive Order on Drug Pricing
Trump Seeks Ideas to Reduce Prescription Drug Costs
BofA Securities Maintains IQVIA Holdings(IQV.US) With Buy Rating, Announces Target Price $190
Prelude to increased tariffs? The Trump administration has initiated a Section 232 investigation into pharmaceuticals and Semiconductors.
① The USA government disclosed on Monday that it has launched an investigation into the impact of imported Pharmaceuticals and Semiconductors on National Security; ② This is widely seen as a prelude to imposing tariffs on prescription drugs and Semiconductors, and it could further escalate the trade war initiated by the USA.
Trump Opened Pharmaceutical, Semiconductor Tariff Probes April 1
IQVIA Holdings Inc. Stock Climbs 3.7%, Outperforms Competitors
Resilience and Growth: IQVIA Holdings' Buy Rating Amid RDS Challenges and TAS Strength
Truist Financial Maintains IQVIA Holdings(IQV.US) With Buy Rating, Announces Target Price $216